Terms: = Lymphoma AND Ki-67 AND Treatment
340 results:
1. treatment patterns, clinical outcomes and gene mutation characteristics of hepatitis B virus-associated mantle cell lymphoma.
Feng J; Fei Y; Gao M; Meng X; Zeng D; Zou D; Ye H; Liang Y; Sun X; Liang R; Zhou H; Wang X; Zhang H
Hematol Oncol; 2024 May; 42(3):e3268. PubMed ID: 38676394
[TBL] [Abstract] [Full Text] [Related]
2. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract] [Full Text] [Related]
3. [Effect of L-Type Amino Acid Transporter 1 Expression on Clinicopathological Features and Prognosis of Non-Hodgkin's lymphoma].
Zhao ZF; Hao XJ; Yang YM; Xu WG; Zhang YX; Yuan XH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):434-438. PubMed ID: 38660848
[TBL] [Abstract] [Full Text] [Related]
4. Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.
Salles G; Chen JMH; Zhang I; Kerbauy F; Wu JJ; Wade SW; Nunes A; Feng C; Kloos I; Peng W; Snider JT; Maciel D; Chan K; Keeping S; Shah B
Adv Ther; 2024 May; 41(5):1938-1952. PubMed ID: 38494543
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides.
Porkert S; Griss J; Hudelist-Venz M; Steiner I; Valencak J; Weninger W; Brunner PM; Jonak C
J Dtsch Dermatol Ges; 2024 Apr; 22(4):532-550. PubMed ID: 38444271
[TBL] [Abstract] [Full Text] [Related]
6. The prognosis of patients with primary pulmonary mucosa-associated lymphoid tissue lymphoma: Treated with surgery or chemotherapy?
Ning Y; He H; Li Q; Zhao D; Xie D
Eur J Cardiothorac Surg; 2024 Mar; 65(3):. PubMed ID: 38400749
[TBL] [Abstract] [Full Text] [Related]
7. [Efficacy and Prognosis of Chemotherapy Regimen Containing BTK Inhibitor in treatment of Recurrent/Refractory Mantle Cell lymphoma].
Chen H; Liu XY; Chang Y; Chen ZQ; Li WQ; Zhang L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):125-131. PubMed ID: 38387910
[TBL] [Abstract] [Full Text] [Related]
8. Initial diagnosis of extranodal NK/T-cell lymphoma in pericardial fluid with concomitant hemophagocytic lymphohistiocytosis (HLH).
Khasawneh A; McGuinness G; Ward N
J Hematop; 2024 Mar; 17(1):27-36. PubMed ID: 38376724
[TBL] [Abstract] [Full Text] [Related]
9. NOT OTHERWISE SPECIFIED T-CELL lymphoma: OUTCOMES OF A SINGLE CENTER STUDY.
Kriachok I; Tytorenko I; Shudrak N; Aleksik O; Stepanishyna Y; Kadnikova T; Pastushenko Y; Shokun N; Rudiyk T; Bushuieva M
Exp Oncol; 2024 Feb; 45(4):474-482. PubMed ID: 38328842
[TBL] [Abstract] [Full Text] [Related]
10. Follicular lymphoma Presenting With Symptomatic Bone Involvement: A Clinicopathologic and Molecular Analysis of 16 Cases.
Sarro R; Bisig B; Guey B; Missiaglia E; Cairoli A; Omoumi P; Letovanec I; Ferry JA; Hasserjian RP; de Leval L
Mod Pathol; 2024 Apr; 37(4):100440. PubMed ID: 38290600
[TBL] [Abstract] [Full Text] [Related]
11. [Analysis of 9 cases of pediatric-type follicular lymphoma].
Li GP; Zhang D; Wang YQ; Li ZY; Yuan FF; Li MH; Wang L; Du JW; Zhang LN; Li YF; Wei XD; Fu YW
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1129-1132. PubMed ID: 38018051
[No Abstract] [Full Text] [Related]
12. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
13. Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review.
Huang F; Ruan Y; He X; Lian H; Yang J
World J Surg Oncol; 2023 Oct; 21(1):342. PubMed ID: 37884941
[TBL] [Abstract] [Full Text] [Related]
14. Clinical features, prognostic stratification, and treatment of advanced-stage non-nasal type extranodal natural killer/T-cell lymphoma: a multi-institutional real-world study.
Wei YC; Liu WX; Qi F; Zhang CG; Zheng BM; Xie Y; Chen B; Zhang D; Liu WP; Fang H; Chai Y; Qi SN; Li YX; Wang WH; Song YQ; Zhu J; Dong M
Ann Hematol; 2024 Jan; 103(1):163-174. PubMed ID: 37817010
[TBL] [Abstract] [Full Text] [Related]
15. The kava chalcone flavokawain B exerts inhibitory activity and synergizes with BCL-2 inhibition in malignant B-cell lymphoma.
Zhao M; Jiang X; Fang J; Lin Y; Li Y; Pei R; Ye P; Lu Y; Jiang L
Phytomedicine; 2023 Nov; 120():155074. PubMed ID: 37716033
[TBL] [Abstract] [Full Text] [Related]
16. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
Levy Yurkovski I; Tadmor T
Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
[TBL] [Abstract] [Full Text] [Related]
17. [Diagnostic and prognostic values of flow cytometry in diffuse large B-cell lymphoma with bone marrow involvement].
Hong Y; Wan WL; Li M; Wang H; Dong F; Jing HM; Ke XY; Zhu MX
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(29):2258-2265. PubMed ID: 37544763
[No Abstract] [Full Text] [Related]
18. Clinical outcome of Mantle Cell lymphoma patients with high-risk disease (high-risk MIPI-c or high p53 expression).
Scheubeck G; Jiang L; Hermine O; Kluin-Nelemans HC; Schmidt C; Unterhalt M; Rosenwald A; Klapper W; Evangelista A; Ladetto M; Jerkeman M; Ferrero S; Dreyling M; Hoster E
Leukemia; 2023 Sep; 37(9):1887-1894. PubMed ID: 37495776
[TBL] [Abstract] [Full Text] [Related]
19. [Primary adrenal NK/T cell lymphoma: a clinicopathologic analysis of six cases].
Zhou SL; Wei JG; Li B; Wang XJ; Gong ZQ; Fan PH; Wang LF; Zhao RJ; Zhang L; Kong LF
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):710-714. PubMed ID: 37408402
[No Abstract] [Full Text] [Related]
20. treatment of older patients with mantle cell lymphoma in the era of novel agents.
Rozental A; Jim HSL; Extermann M
Leuk Lymphoma; 2023 Sep; 64(9):1514-1526. PubMed ID: 37357622
[TBL] [Abstract] [Full Text] [Related]
[Next]